US FDA Asks For Comments On Reauthorizing OMUFA, A Program Still New To OTC Industry

Agency conducting all-day online meeting on 28 September to discuss proposed first reauthorization of OMUFA program established with its first five-year authorization in 2020 in legislation to overhaul the OTC monograph program.

• Source: Shutterstock

An upcoming US Food and Drug Administration workshop is on an OTC program established four years ago but might seem like it started only yesterday, its Over-the-Counter Monograph Drug User Fee program.

The agency is conducting an all-day public meeting online on 28 September from its White Oak headquarters campus in Silver...

More from Regulation

More from Policy & Regulation